$AXT
相关推文
按时间倒序
-
AXTI 不只是 InP 基板那么简单
散户空头真的不该碰 $AXTI。 我一直看到有人把 $AXTI 误解成只有 “InP 基板”，总是拿住友来对比，但我一直没出声。 这是错的。 它们实际上掌握了整个 InP 供应链 40% 以上，这也是机构愿意给它们融资的原因。 它们握有很多卡点，不只是 InP 基板。 正如海湾地区那样，削减大约 20% 的供应就会是灾难；如果再叠加另外 3-4 个卡点，后果更严重。 -> 所有原材料（铟、镓、锗）。 Vital 和 $AXTI（自有、金美）与中国公司一起构成寡头；而西方的 5N 等只占很小一部分份额。 由于中国（Vital、AXT）掌握多数份额。 -> pBN 坩埚卡点： $AXTI 也是另一个巨大的卡点（博宇）。还有信越/摩根等少数玩家，但这又是精炼层面的一个瓶颈。 InP 基板： $AXT / 住友在这里是双寡头，JX、$COHR 只占很小比例。 这里面还有很多其他工艺（比如红磷）处于中间环节（例如日本化学/理沙）。 这是一个材料问题。 $COHR 不能在没有 AXT 控制的所有上游材料和精炼环节的情况下，直接做出 InP 基板。 如果 $LITE 的 CEO 因为 InP 基板睡不着觉，那么 50 亿美元估值对维持西方超大规模云厂商的建设上线来说根本不算什么。 日本的上游材料正在被出口管制，而 AXT 把这些都牢牢握在手里。 所以总的来说：我看到很多空头把事情混同成 “只是 InP 基板” 了。 实际上是所有铟、镓 -> 精炼加工 -> pBN 坩埚，再到最终由它们与住友共同完成的 InP 基板生产过程。 如果 Vital 和多个上游卡点停止供货，下游西方 InP 基板厂商就会受影响。 AXTI 会变成一个小型垄断。 估值来自掌控整条供应链，而不只是连机构分析师都搞不懂的 “InP 基板制造”。
英文原文
Retail short sellers should really not touch $AXTI. I keep seeing people misunderstand $AXTI as only "InP Substrate" with Sumitomo, over and over but just never made a comment. This is wrong. They are literally 40%+ of the InP supply chain, which is why institutions are funding them. They hold MANY chokepoints, not just InP Substrates. As seen with the Gulf, removing ~20% of a supply is catastrophic, but do that with 3-4 other chokepoints. -> All the raw materials (indium, gallium, germanium). Vital and $AXTI (captive, JinMei) are the duopoly alongside Chinese companies. With Western 5N and others only holding a small fractional share. Since China (Vital, AXT) controls majority. -> pBN Crucible chokepoints: $AXTI is a another massive chokepoint (BoYu). there's a few other players like ShinEtsu/Morgan/etc, but this is another bottleneck in refinery layers. InP substrates: $AXT / Sumitomo are duopoly here, with JX, $COHR holding just a tiny percentage. There's many other processes (eg. Red Phosphorus) here too (eg. Nippon Chemical/Rasa) in the middle. This is a materials problem. $COHR can't just make InP substrates without all the upstream materials + refineries that $AXT controls. If $LITE CEO can't sleep at night because of InP substrates, $5B valuations mean nothing to the Western hyperscaler buildout stay online. Japan is actively getting export controlled on upstream materials, while AXT holds them all captive. So TLDR: It's not just "InP Substrates" that i see a lot of short sellers conflating. It's all the indium, gallium -> refinery processing -> pBN Crucible that goes into the final duopoly InP substrate creation process they share with Sumitomo. if Vital and multiple chokepoints upstream stops shipping, downstream to the Western InP substate makers. AXTI becomes a mini-monopoly. The valuation comes from owning the entire supply chain, not just "InP substrate creation" that even institutional analysts dont understand.
-
认为不要只盯价格波动，$AXT 和 $SIVE 的长期价值仍可能非常高。
什么都没有？如果有人愿意在限价买单很少的情况下，把给 $JBL、Ayar、$MRVL Celestial 等客户供光源的公司按 2.5 亿美元市值去市价砸盘或者止损，他们当然可以这么做。 我第一次发 $AXT 时，它从 15 美元跌了 20% 到 12 美元，现在已经大概 60 美元了。 最好的办法是看市值，而不是看中途的百分比波动，因为沿途一定会有很多波动。 $SIVE 可能是我现在最喜欢的光子板块机会之一，我个人觉得如果大家 6 个月后回头看，现在的估值一定会让人拍桌子。
英文原文
Nothing? If people want to market sell/stop loss the laser supplier to $JBL, Ayar, $MRVL Celestial and others at a $250m, when there's low limit buys, they're free too. $AXT dropped 20% to $12 when I first posted it at $15 and now it's ~$60. Best thing to do is look at market cap and not the % fluctuations, since there's going to be a lot of volatility along the way. $SIVE is probably one of my favorite photonic sector opportunity right now given valuation. And I personally think if people looked back 6 months later, they'll be pounding the table at current valuations.
-
反驳对$AXT催化剂的邀功论，强调新催化剂与旧持仓的本质区别。
并非如此，他们之前的帖子围绕的是“智能家居和个人助理”，完全没有提及 Openclaw。Openclaw 的变体是在他们发帖之后才发布的。 人们可能早在多年前就持有 $AXT 的做多仓位，但当出现新的催化剂时，情况有着实质性的不同。 仅仅因为早期有模糊的股票代码提及，并不意味着他们正确预判了催化剂，不幸的是，人们试图为后来发生的事情邀功。
英文原文
Not really, their post was around “smart homes and personal assistants” without one mention of openclaw. Openclaw variants were released after their post. People can be long AXT years ago but it’s materially different when there’s a new catalyst. Just because there’s a vague ticker mention earlier on doesn’t mean they got the catalyst correct and it’s unfortunate people try to claim credit for what happens later.
-
确认InP供应链属国安优先，短期加剧ATI瓶颈，AXT略偏多。
好问题，我当时没把1+1联系起来，错过了对$AXTI的单跳关联影响。我的观点是，短期/中期基本无影响，但由于有6个月的空窗期，对AXT略微偏多。Emcore相比之下非常小，但美国政府正试图掌控上游控制的任何微小份额。这证实了美国政府现在将磷化铟(InP)供应链视为国家安全优先事项，并验证了我之前提出的InP瓶颈论点。TLDR：行政令接管InP供应链资产是为了长期摆脱对中国的依赖，但短期/中期$ATI的瓶颈甚至更严重。
英文原文
Good question, I didn't put 1+1 together at the time and missed the one-hop relational impact with $AXTI. My take is basically, no impact short/medium term, but leans slightly positive for AXT since there's a 6 month limbo. Emcore is very tiny in comparison, but US gov is trying to gain control of any little % of the upstream control. This was just affirmation that US government now views InP supply chains as a national security priority and is validating the InP bottlenek thesis I put out earlier. TLDR: EOs seizing InP supply chain assets was a move to regain independence from China long term, but short-medium term bottleneck is even more severe with $ATI
-
Craig-Hallum上调AXTI评级至买入，看好其InP垄断地位带来的重估潜力。
最新消息：Craig-Hallum 将 $AXTI 评级上调至“买入”，目标价 $26，涨幅 160%。 他们指出 AXT 受益于“三重动态”，即： - 限制竞争对手（住友、JX） - 同时在 Northland 融资后增加产能。 被《华尔街日报》评为第一的半导体分析师 Shannon 预计 AXT 2028 年每股收益为 $0.75，假设 AXT 是“正常”成长股，给予 30 倍估值。 关键国防/AI 供应链（如 Heico 或专业芯片公司）通常交易在 50-60 倍，这将使 $AXTI 目标价达到 $37.50（作为成长股）。 然而，如果“供应冲击”论点成立且 $AXT 成为战略垄断者，其估值逻辑将像 $MU 或 Sandisk 一样彻底重构，我们可能会看到大幅重估。 这是一种“阶梯式”估值，分析师通常会逐步上调目标价。如果 $AXTI 下周涨至 $28，他可能会发布新报告将其上调至 $32。 机构正在验证这一论点，但在价格和 X 上的 alpha 上均落后。
英文原文
Just in: Craig-Hallum re-rates $AXTI to "Buy" with a $26 price target, a 160% increase. They stated AXT benefits from a "trifecta of dynamics" that put: - constraints on competitors (Sumitomo, JX) - while increasing capacity after Northland's Capital raise. Shannon, ranked as the #1 Semiconductor Analyst on WSJ, pegs AXT at $0.75 EPS by 2028, applying a 30x multiple by assuming AXT is a "normal" growth company. Critical defense/AI supply chains (like Heico or specialized chip firms) can easily trade at 50x-60x, which would set $AXTI at a $37.50 PT (for a growth company). However, if the "Supply Shock" thesis holds and $AXT becomes a strategic monopoly, the math completely breaks like $MU or Sandisk, and we might see a massive re-rating upward. This is a "Step-Ladder" valuation, analysts typically walk the target up. If $AXTI goes to $28 next week, he will likely issue a new note raising it to $32. Institutions are validating the thesis, but are trailing both the price and alpha on X.
-
探讨InP原料与衬底瓶颈差异，指出原料冲击利好AXT而非Sumitomo。
@zephyr_z9 我很好奇。鉴于磷化铟(InP)衬底控制和磷化铟(InP)材料是两个不同的瓶颈，你会更看重哪一个？ 如果上游的磷化铟(InP)原料供应出现冲击，主要的受益者将是像AXT/DOWA这类公司，而不是无法捕获上行收益的住友电工(Sumitomo)。
英文原文
@zephyr_z9 I’m curious. Would you place more value on InP substrate control or indium phosphide since they’re two different bottlenecks? If InP feedstock has a supply shock upstream, the main beneficiaries would be your AXT/DOWA type companies instead of Sumitomo that don’t capture upside